October 2022 - TinyGems

MondayOct 31, 2022 9:00 am

Lexaria Bioscience Corp. (NASDAQ: LEXX) Moves to Address Adverse Effects of Hypertension with DehydraTECH(TM) – CBD

Lexaria is a drug delivery technology company developing DehydraTECH-CBD as a prospective registered treatment for hypertension and potentially other disease states beyond hypertensionThe company has undertaken multiple de-risking hypertension studies that have not only evidenced that DehydraTECH-CBD is safe and well tolerated, but have also shown that it reduces blood pressure and arterial stiffnessHypertension is a leading contributor to deaths in the United States, damaging organs such as the heart, brain, and kidneys, yet only a tiny proportion of patients have it under control Hypertension, an area of interest and focus for drug delivery technology company Lexaria Bioscience (NASDAQ: LEXX),…

WednesdayOct 26, 2022 10:30 am

Cepton, Inc. (NASDAQ: CPTN) Enables Tier-1 OEMs To Prepare for Safety-Centric Future with Cost-Effective Lidar Integration

Automotive industry faces massive disruption led by adoption of emission reduction mandates, software-centric driving systems, and ADAS/AV technologyEntering execution phase of higher levels of ADAS and AV technology with several OEMs preparing to build fully or near-fully autonomous vehicles ready for public roadsLidar complements camera-based perception technology by “seeing” things in 3D rather than 2DCepton is taking lidar mainstream by engaging with leading global automotive OEMs to cost-effectively deploy lidar at scale The automotive industry has faced massive disruption in the last few years, led primarily by the adoption of emission reduction mandates, software-centric driving systems, and autonomous vehicle (“AV”)…

TuesdayOct 25, 2022 9:45 am

Lexaria Bioscience Corp.’s (NASDAQ: LEXX) Potential Hypertension Medication Poised to Reduce Risk of Blood-Pressure-Induced Dementia, Cognitive Decline

Lexaria Bioscience is a global innovator in drug delivery platforms that has developed the patented DehydraTECH(TM) technology for improved delivery of bioactive compoundsThe company is currently evaluating DehydraTECH-processed CBD as a potential treatment for high blood pressureLong-term studies have shown that high blood pressure can increase the risk of developing dementia in later lifeExperts, however, believe that hypertension medication could slow the pace of the cognitive declineIn addition to helping hypertension patients keep their condition under control, Lexaria’s DehydraTECH-CBD, which has so far been shown to be safe and well tolerated, could potentially help reduce the risk of dementia Blood…

MondayOct 24, 2022 9:45 am

Cepton, Inc. (NASDAQ: CPTN) to Help Accelerate Advancement of Vehicle Autonomy; Collaborates with NVIDIA DRIVE Sim(TM) to Add Its Lidar Models into Simulation Platform for Autonomous Driving

Cepton announced a collaboration with NVIDIA, a cutting-edge platform for large-scale, accurate multi-sensor simulation for autonomous driving; developed sensor ecosystem is essential for AV development and validation in simulationNVIDIA DRIVE Sim(TM) allows users to test Cepton lidars and accelerate and scale deployment; Company expects to accelerate development of lidars for assisted and autonomous driving for global customers through this collaboration At the recent IAA Transportation 2022 conference, Cepton exhibited its Nova lidar integrated into a heavy-duty truck headlamp by ZKW Group GmbH “Lidar is essential to autonomous mobility, but deploying lidar at scale entails extensive testing and validation, sometimes in scenarios…

ThursdayOct 20, 2022 1:30 pm

Commercial Traffic Infrastructure Projects and Supply Chain Tech Innovations by Freight Technologies Inc. (NASDAQ: FRGT) Highlight Economic Value of Cross-border Trade

Houston-headquartered Freight Technologies Inc. is an AI-driven technology developer focused on supporting the commercial trucking industry through efficient and transparent operationsRecent discussion of cross-border traffic infrastructure projects by Mexico’s and the United States’ ambassadors underscores the importance the two nations place on their mutual trade infrastructureFreight Technologies’ Fr8App B2B marketplace helps improve communications between carriers and shippers so they can more efficiently match loads and avoid empty milesThe company is reporting new record quarterly revenue and expects improving market conditions as the nation continues to rebound from COVID’s economic effects When Mexico’s ambassador to the United States Esteban Moctezuma outlined…

ThursdayOct 20, 2022 9:45 am

Cepton, Inc.’s (NASDAQ: CPTN) Lidar Surveillance Solutions Offer Distinct Advantages Over Camera-Only Systems – Protecting Privacy and Eliminating AI Bias

Commonly used surveillance cameras employ AI-powered facial recognition technology that can compromise privacy and lead to biased decisionsLidar may hold the key to privacy-focused solutions by feeding purely behavior-based and biometric-free data into systemsCepton’s lidar-based solutions are developing substantial traction with pilot systems in-place for airport terminal monitoring, highway e-tolling, early-warning intrusion detection, and railway obstacle detectionCepton is currently engaged in discussions with every top-10 global automotive OEM to provide lidar-based perception solutions for automotive applications (e.g., AV and ADAS systems) Facial recognition technology is increasingly being used to monitor public and private spaces, leading to widespread concerns that AI-enabled…

WednesdayOct 19, 2022 11:15 am

Lexaria Bioscience Corp. (NASDAQ: LEXX) Using Novel DehydraTECH(TM) Technology to Address Unmet Antihypertension Drug Market

Research has shown that co-occurring conditions may be linked to high blood pressure, including bone aging and mental illness The antihypertension drug market is anticipated to rise due to the launch of novel pharmaceuticals and diagnostic agents Valued at US $30.2 billion in 2021, the market is expected to grow at a CAGR of 3%, resulting in a value of US $40 billion by 2031 Lexaria’s patented DehydraTECH(TM) technology offers higher bioavailability of active pharmaceutical ingredients due to, in part, bypassing first-pass-liver processing, improving the speed of onset, and brain absorption The American Heart Association (“AMA”) refers to high blood…

WednesdayOct 19, 2022 9:00 am

Flora Growth Corp. (NASDAQ: FLGC) Building Portfolio of Brands that Resonates with End Consumers as It Targets Margins and Profitability

Flora Growth is a global cannabis company building a connected, design-led collective of plant-based wellness and lifestyle brandsThe company’s portfolio of brands is designed to deliver the most compelling customer experiences in the worldThrough its M&A strategy, Flora Growth has brought on board brands like JustCBD, Vessel Brands Inc., Masaya, No Cap Hemp Co., and MambeFlora hopes to establish meaningful connections with consumers through these brands, which will enable it to increase its margins and profitability The cannabis industry has gone global, undergoing a sea change in commercialization, normalization, and liberalization. According to a report by New Frontier Data, this…

MondayOct 17, 2022 10:30 am

Golden Matrix Group Inc. (NASDAQ: GMGI) Thrives in an Industry Where Content is King

Google recently announced the closure of its Google Stadia gaming business, a decision which may have partly been underpinned by the dearth of new gaming titles available on the platformContent has remained a crucial driver of success within the iGaming industry, a factor which Golden Matrix Group have sought to cater toThrough their proprietary GM-X turnkey solution, the company provides its licensing partners with access to upward of 10,000 games drawn from over 25 gaming studios On November 19, 2019, Google made an announcement that was set to potentially change the face of the gaming universe as we know it.…

MondayOct 17, 2022 9:45 am

Lexaria Bioscience Corp.’s (NASDAQ: LEXX) Drug Development Program Seeking to Provide Safe, Well-Tolerated, Effective Antihypertensive Medication Amid Continued Reports of Suboptimal Adherence to Existing Treatments

Lexaria Bioscience, a global innovator in drug delivery technology, has developed a potential treatment for hypertension using the company’s patented DehydraTECH(TM) platform, now shown in several human studies to reduce blood pressure and arterial stiffnessLexaria’s antihypertensive drug development program comes at a time when researchers are documenting poor control of hypertension among both men and women, partly due to suboptimal adherence to existing antihypertension medicationReasons advanced for the suboptimal adherence include lack of awareness or treatment, increased number of prescribed medications, and major adverse effects of the prescribed drugsLexaria has so far shown that its DehydraTECH-CBD is not only effective…

Spotlighting undiscovered companies with enormous upside potential.

Contact us: (310) 299-1717

Month: October 2022